TW227000B - - Google Patents

Info

Publication number
TW227000B
TW227000B TW081100891A TW81100891A TW227000B TW 227000 B TW227000 B TW 227000B TW 081100891 A TW081100891 A TW 081100891A TW 81100891 A TW81100891 A TW 81100891A TW 227000 B TW227000 B TW 227000B
Authority
TW
Taiwan
Prior art keywords
pct
sec
date
ring
fused
Prior art date
Application number
TW081100891A
Other languages
English (en)
Chinese (zh)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of TW227000B publication Critical patent/TW227000B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
TW081100891A 1991-02-13 1992-02-10 TW227000B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
TW227000B true TW227000B (enExample) 1994-07-21

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081100891A TW227000B (enExample) 1991-02-13 1992-02-10

Country Status (29)

Country Link
US (1) US5358953A (enExample)
EP (1) EP0572425B1 (enExample)
JP (1) JP2506541B2 (enExample)
KR (1) KR970005302B1 (enExample)
CN (1) CN1040326C (enExample)
AT (1) ATE109482T1 (enExample)
AU (1) AU650322B2 (enExample)
BR (1) BR9205615A (enExample)
CA (1) CA2099381C (enExample)
CZ (1) CZ280504B6 (enExample)
DE (1) DE69200304T2 (enExample)
DK (1) DK0572425T3 (enExample)
EG (1) EG20085A (enExample)
ES (1) ES2059212T3 (enExample)
FI (1) FI933531L (enExample)
GB (1) GB9102997D0 (enExample)
HU (2) HUT65947A (enExample)
IE (1) IE65125B1 (enExample)
IL (1) IL100887A (enExample)
MX (1) MX9200589A (enExample)
MY (1) MY108437A (enExample)
NO (1) NO300592B1 (enExample)
NZ (1) NZ241597A (enExample)
PL (1) PL169304B1 (enExample)
RU (1) RU2114845C1 (enExample)
TW (1) TW227000B (enExample)
WO (1) WO1992014734A1 (enExample)
YU (1) YU48238B (enExample)
ZA (1) ZA921005B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
EP0775139A1 (en) * 1994-08-10 1997-05-28 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5866588A (en) * 1995-04-05 1999-02-02 British Biotech Pharmaceuticals Ltd. Imidazopyridine derivatives
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
CA2417960C (en) 2000-08-04 2012-07-10 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
ES2579635T3 (es) 2003-05-15 2016-08-12 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
AU2008349239B2 (en) 2008-01-30 2012-12-06 Nippon Zoki Pharmaceutical Co., Ltd. Piperidine derivative
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
EP2727919B1 (en) * 2011-06-28 2019-05-08 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Benzocycloheptanethiophene derivatives for anti-allergic reactions
SG10201608087WA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
KR102032400B1 (ko) 2011-10-10 2019-10-15 앰피오 파마슈티컬스 인코퍼레이티드 퇴행성 관절 질환의 치료
BR112014008036A2 (pt) * 2011-10-28 2017-04-11 Ampio Pharmaceuticals Inc tratamento de rinite
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
JP6723222B2 (ja) 2014-08-18 2020-07-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 関節病態の治療
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (enExample) * 1963-04-24
JPH03503889A (ja) * 1988-03-15 1991-08-29 ジー．ディー．サール　アンド　カンパニー ＰＡＦ拮抗剤としての１Ｈ／３Ｈ‐［４‐（Ｎ，Ｎ‐ジシクロアルキル／分枝アルキルカルボキサミド）‐ベンジル］イミダゾ［４，５‐ｃ］ピリジン類
EP0339978B1 (en) * 1988-04-28 1996-08-21 Schering Corporation Fused polycyclic compounds, compositions, methods of manufacture, and their use as PAF antagonists, antihistamines and/or antiinflammatory agents
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
JPH0678340B2 (ja) * 1990-05-09 1994-10-05 フアイザー・インコーポレイテツド 喘息、関節炎および関連疾患の治療におけるアザベンジミダゾール

Also Published As

Publication number Publication date
MX9200589A (es) 1992-10-01
ATE109482T1 (de) 1994-08-15
IE65125B1 (en) 1995-10-04
ES2059212T3 (es) 1994-11-01
JP2506541B2 (ja) 1996-06-12
DE69200304D1 (de) 1994-09-08
JPH06504992A (ja) 1994-06-09
CS42592A3 (en) 1992-09-16
EG20085A (en) 1997-05-31
CN1040326C (zh) 1998-10-21
MY108437A (en) 1996-09-30
NO932889L (no) 1993-08-13
CN1064275A (zh) 1992-09-09
YU14392A (sh) 1994-11-15
EP0572425B1 (en) 1994-08-03
FI933531A0 (fi) 1993-08-10
CA2099381C (en) 1996-07-09
PL169304B1 (pl) 1996-06-28
HUT65947A (en) 1994-08-29
WO1992014734A1 (en) 1992-09-03
IL100887A0 (en) 1992-11-15
NZ241597A (en) 1993-04-28
KR970005302B1 (ko) 1997-04-15
NO300592B1 (no) 1997-06-23
HU211202A9 (en) 1995-11-28
HU9302327D0 (en) 1993-10-28
GB9102997D0 (en) 1991-03-27
DE69200304T2 (de) 1994-12-08
FI933531A7 (fi) 1993-08-10
IE920449A1 (en) 1992-08-12
AU1168392A (en) 1992-09-15
EP0572425A1 (en) 1993-12-08
AU650322B2 (en) 1994-06-16
YU48238B (sh) 1997-08-22
FI933531L (fi) 1993-08-10
CZ280504B6 (cs) 1996-02-14
NO932889D0 (no) 1993-08-13
RU2114845C1 (ru) 1998-07-10
CA2099381A1 (en) 1992-08-14
US5358953A (en) 1994-10-25
BR9205615A (pt) 1994-05-17
DK0572425T3 (da) 1994-09-12
IL100887A (en) 1996-01-19
ZA921005B (en) 1993-08-12

Similar Documents

Publication Publication Date Title
TW227000B (enExample)
YU48426B (sh) Novi supstituisani pirazolilpirazoli, postupak njihovog dobijanja, medjuproizvodi za njihovo dobijanje i primena kao sredstava sa herbicidnim delovanjem
ES2162061T3 (es) Derivados de piperidina como antagonistas de la neuroquinina.
UA26427A (uk) Похідhі ксаhтиhу у вигляді суміші ізомерів або іhдивідуальhих ізомерів, що мають властивість аhтагоhіста адеhозиhу
BG105513A (en) Substituted benzopyran analogs for the treatment of inflammation
YU84791A (sh) Biciklicni 1-aza-cikloalkalni
YU4397A (sh) Novi supstituisani oksazolidinoni
FI954678A0 (fi) Keinotekoiset lasimaiset kuidut
RU93054165A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция, способ лечения
FI922341A0 (fi) Piperidin- och pyrrolidinderivat.
DE69102762D1 (de) Beta-phenylisoserinderivate, ihre herstellung und ihre anwendung.
YU4393A (sr) Supstituisani heksahidroazepinoni i tetrahidrobenzazepinoni
ATE64373T1 (de) Muscarin-rezeptor-antagonisten.
ES2095995T3 (es) Procedimiento para la obtencion de 2,2-difluorbenzo(1,3)dioxol-carbaldehidos y nuevos productos intermedios.
MX9606654A (es) Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina.
TR199901395T2 (xx) Yeni karboksi ikameli siklik karboksamid t�revleri.
DE3484375D1 (de) Pharmazeutische zusammenstellung fuer die prophylaxe oder behandlung von tierhaltungsketose.
FI973558L (fi) Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi
IL62226A0 (en) Cephalosporins,their preparation and pharmaceutical compositions containing them
ATE110367T1 (de) Kalziumantagonisten.
PT100223A (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
DE69001794D1 (de) Phenothiazinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES2084547B1 (es) Antagonistas benzopiranicos y relacionados de leucotrieno b4.
KR920006246A (ko) 온돌용 세라믹 조성물
NL7609616A (en) (5)-Amino sulphonyl-benzene-(1,3)-dioxamic acids and esters - inhibitors of histamine release, useful e.g. in asthma treatment